XTX Topco’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
XTX Topco's ADPT Position: Q2 2026 in Review
XTX Topco increased its Adaptive Biotechnologies (ADPT) stake by 395% in Q2 2026, buying an estimated $1.38M and bringing the position to 113,043 shares worth $2.42M. The position accounts for 0.03% of the portfolio, ranked #926.
XTX Topco first reported a position in ADPT in Q1 2023 and has held it in 9 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- XTX Topco held 113,043 shares of Adaptive Biotechnologies worth $2.42M as of Q2 2026.
- XTX Topco bought 90,214 Adaptive Biotechnologies shares in Q2 2026, an estimated $1.38M.
- Adaptive Biotechnologies made up 0.03% of XTX Topco's portfolio in Q2 2026, its #926 holding.
- XTX Topco first reported a position in Adaptive Biotechnologies in Q1 2023 and has held it in 9 quarters since.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.